Results of a survey of small-animal practitioners on the perceived clinical efficacy and safety of an oral nutraceutical

Preventive Veterinary Medicine

Volumn 38, Issue 1, 1999, Pages 65-73

  Anderson, M A ^a   Slater, M R ^b   Hammad, T A ^c  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Chondroitin sulfate; Chondroprotective agent; Clinical efficacy; Degenerative joint disease; Dogs; Glucosamine; Lameness; Nutraceutical; Survey

Indexed keywords

ALTERNATIVE MEDICINE; ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; ARTHROPATHY; ARTICLE; DOG; DOG DISEASE; HEALTH FOOD; HEALTH PERSONNEL ATTITUDE; HUMAN; ORAL DRUG ADMINISTRATION; QUESTIONNAIRE; UNITED STATES; VETERINARY MEDICINE;

ADMINISTRATION, ORAL; ANIMALS; ATTITUDE OF HEALTH PERSONNEL; COMPLEMENTARY THERAPIES; DOG DISEASES; DOGS; HEALTH FOOD; HUMANS; JOINT DISEASES; LAMENESS, ANIMAL; QUESTIONNAIRES; UNITED STATES; VETERINARIANS;

EID: 0033033607     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5877(98)00105-6     Document Type: Article

References (21)

1. Anderson, M.A., Beaver, D.P., 1996. Glycosaminoglycans in the treatment of degenerative joint disease in small animals. Emerg. Science Technol. pp. 21-22.
2. Boothe D.M., Camp R., Gelfand L., Ross G., Turkell A., Willer R. Discussion of degenerative joint disease in dogs. Canine Pract. 21:1996;1-16.
3. Burkhardt D., Gosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Sem. Arthritis Rheuma. 17:1987;3-34.
4. DeCamp, C.E., 1996. Kinematic and kinetic analysis: Principles, pearls and pitfalls. Proceed. 6th annual A.C.V.S. Symposium. p. 208.
5. DeHaan J.J., Goring R.L., Beale B.S. Evaluation of polysulfated glycosaminoglycan for the treatment of hip dysplasia in dogs. Vet. Surg. 23:1994;177-181.
6. Dillman, D.A., 1978. Mail and Telephone Surveys: The Total Design Method. Wiley Interscience Publications, New York. pp 1-25.
7. Friedman, L.M., Furberg, C.D., DeMets, D.L., 1996. Fundamentals of Clinical Trials. PSG Publishing Company, Inc., Littleton, MA. pp. 1-225.
8. Hanson R.R. Mode of action of oral chondroprotective agents in equine practice. J. Equine Pract. 17:1995;6-9.
9. Hanson R.R. Oral glycosaminoglycans in treatment of degenerative joint disease in horses. J. Equine Pract. 18:1996;18-22.
10. Hanson, R.R., Smalley, L.R., Huff, G.K., White, S., Hammad, T., 1996. Treatment of an oral glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Proceed. 35th Br. Equine Vet. Assoc. Congress. pp. 74.
11. Mankin H.J., Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J. Bone Joint Surg. 52:1970;424-434.
12. Mankin H.J., Johnson M.E., Lippiello L., Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology and biochemical and metabolic data. J. Bone Joint Surg. 53:1971;523-534.
13. Martin, S.W., Meek, A.H., Willeberg, P., 1987. Veterinary Epidemiology. Iowa State University Press, Ames, Iowa. pp. 149-158.
14. McNamara P.S., Barr S.C., Erb H.N. Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am. J. Vet. Res. 57:1996;1390-1394.
15. McNamara, P.S., Barr, S.C., Idouraine, A., Lipiello, L., 1997. Effects of an oral chondroprotective agent (Cosequin) of cartilage metabolism and canine serum. Proceed. 24th Annual Vet. Orthop. Soc. Symposium. pp. 35.
16. Moore M.G. Promising responses to a new oral treatment for degenerative joint disorder. Canine Pract. 2:1996;7-11.
17. Noordhuizen, J.P.T.M., Frankena, K., van der Hoofd, E.M., Graat E.A.M., 1997. Application of Quantitative Methods in Veterinary Epidemiology. Wageningen Press, Wageningen, The Netherlands. pp. 427-440.
18. Rashad S., Revell P., Hemingway A., Low F., Rainsford K., Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet. 2:1989;519-522.
19. Weinstein, M.J., Mongil, C.M., Smith, G.K., 1995a. Orthopedic conditions of the Rottweiler - Part I Compend. Cont. Ed. Pract. Vet. 17, 813-830.
20. Weinstein, M.J., Mongil, C.M., Rhodes, W.H., Smith, G.K., 1995b. Orthopedic conditions of the Rottweiler - Part II. Compend. Cont. Ed. Pract. Vet. 17, 925-939.
21. Vasseur, P.B., 1993. The stifle joint. In: Slatter, D.H. (Ed.), Small Animal Surgery. W.B. Saunders Company, Philadelphia, PA. pp. 1817-1866.